 |
|
Regional Brain Metabolic Correlates of  -Methylparatyrosine–Induced Depressive Symptoms
Implications for the Neural Circuitry of Depression
J. Douglas Bremner, MD;
Meena Vythilingam, MD;
Chin K. Ng, PhD;
Eric Vermetten, MD;
Ahsan Nazeer, MD;
Dan A. Oren, MD;
Robert M. Berman, MD;
Dennis S. Charney, MD
JAMA. 2003;289:3125-3134.
Context We previously used positron emission tomography (PET) measurement of brain metabolism with 18fluorodeoxyglucose to show that patients receiving selective serotonin reuptake inhibitors (SSRIs) who have a tryptophan depletion–induced return of depressive symptoms have an acute decrease in metabolism in orbitofrontal cortex, dorsolateral prefrontal cortex, and thalamus. Many patients with depression in remission while taking norepinephrine reuptake inhibitors (NRIs) (but not SSRIs) experience a return of depressive symptoms with depletion of norepinephrine and dopamine using  -methylparatyrosine (AMPT).
Objective To assess brain metabolic correlates of AMPT administration in patients with depression in remission while receiving NRIs.
Design, Setting, and Participants Randomized, controlled, double-blind trial in which 18 patients recruited in 1997-2000 from the general community who had depression in remission while taking NRIs had PET imaging in a psychiatric research unit following AMPT and placebo administration.
Interventions After initial medication with desipramine and follow-up until response, patients underwent active AMPT (five 1-g doses administered orally over 28 hours) and placebo (diphenhydramine hydrochloride, five 50- mg doses administered similarly) catecholamine depletion challenges in randomized order of assignment, after which PET imaging was performed on day 3 of each condition. Both study conditions were performed 1 week apart.
Main Outcome Measures Regional brain metabolism rates in patients with and without AMPT-induced return of depressive symptoms.
Results AMPT-induced return of depressive symptoms was experienced by 11 of the 18 patients and led to decreased brain metabolism in a number of cortical areas, with the greatest magnitude of effects in orbitofrontal (P = .002) and dorsolateral prefrontal (P = .03) cortex and thalamus (P = .006). Increased resting metabolism in prefrontal and limbic areas predicted vulnerability to return of depressive symptoms.
Conclusions Different neurochemical systems that mediate depression may have effects on a common brain circuitry. Baseline metabolism in successfully treated depressed patients may predict vulnerability to future episodes of depression.
Author Affiliations: Departments of Psychiatry and Behavioral Sciences and Radiology and the Emory Center for Positron Emission Tomography, Emory University School of Medicine, Atlanta, Ga (Drs Bremner, Vermetten, and Nazeer); Atlanta Veterans Affairs Medical Center, Decatur, Ga (Drs Bremner, Vermetten, and Nazeer); Mood and Anxiety Disorders Program, National Institute of Mental Health, Bethesda, Md (Drs Vythilingam and Charney); Department of Radiology, University of Louisville, Louisville, Ky (Dr Ng); and Department of Psychiatry, Yale University School of Medicine, New Haven, Conn (Drs Oren and Berman).
RELATED LETTER
Neurochemical Aspects of Susceptibility to Depression
Pradeep J. Nathan
JAMA. 2003;290(10):1315-1316.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Neural Response to Catecholamine Depletion in Unmedicated Subjects With Major Depressive Disorder in Remission and Healthy Subjects
Hasler et al.
Arch Gen Psychiatry 2008;65:521-531.
ABSTRACT
| FULL TEXT
High-Resolution Brain SPECT Imaging and Eye Movement Desensitization and Reprocessing in Police Officers With PTSD
Lansing et al.
J. Neuropsychiatry Clin. Neurosi. 2005;17:526-532.
ABSTRACT
| FULL TEXT
Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system
Remy et al.
Brain 2005;128:1314-1322.
ABSTRACT
| FULL TEXT
Functional Brain Imaging Alterations in Acne Patients Treated With Isotretinoin
Bremner et al.
Am. J. Psychiatry 2005;162:983-991.
ABSTRACT
| FULL TEXT
Neural and Behavioral Responses to Tryptophan Depletion in Unmedicated Patients With Remitted Major Depressive Disorder and Controls
Neumeister et al.
Arch Gen Psychiatry 2004;61:765-773.
ABSTRACT
| FULL TEXT
Deficits in Hippocampal and Anterior Cingulate Functioning During Verbal Declarative Memory Encoding in Midlife Major Depression
Bremner et al.
Am. J. Psychiatry 2004;161:637-645.
ABSTRACT
| FULL TEXT
Neurochemical Aspects of Susceptibility to Depression
Nathan
JAMA 2003;290:1315-1316.
FULL TEXT
The Ubiquity of Depression
JWatch Psychiatry 2003;2003:1-1.
FULL TEXT
Awareness About Depression: Important for All Physicians
Glass
JAMA 2003;289:3169-3170.
FULL TEXT
|
